Biora Therapeutics, Inc. Retained Earnings
Biora Therapeutics, Inc. had Retained Earnings of -$967.08 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-11-14
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$967.08M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$948.68M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$955.15M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$950.96M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-09-30 | -$967.08M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$948.68M 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$955.15M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$950.96M 10-Q · filed 2024-11-14 |
| 2023-09-30 | -$935.54M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$862.09M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$844.28M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$826.84M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$813.12M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$808.01M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$802.49M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$788.69M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$695.81M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$652.07M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$573.54M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$541.27M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$465.75M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$418.68M 10-Q · filed 2020-08-14 |
| 2019-12-31 | -$348.48M 10-K · filed 2021-03-18 |